{
    "title": "US FDA approves Johnson & Johnson's blood cancer therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12392963/US-FDA-approves-J-Js-blood-cancer-therapy.html",
    "date": "2023-08-10",
    "keywords": [
        "cancer",
        "treatment",
        "talvey",
        "therapy",
        "immune",
        "myeloma",
        "type",
        "blood",
        "cell",
        "price",
        "company",
        "duration",
        "year",
        "approval",
        "aug",
        "johnson",
        "thursday",
        "food",
        "drug",
        "administration",
        "difficulttotreat",
        "class",
        "bodys",
        "system",
        "month",
        "dosing",
        "jampj",
        "pricing",
        "range",
        "injection",
        "fda",
        "tecvayli",
        "bispecific",
        "antibody",
        "kind",
        "protein",
        "gprc5d",
        "plasma",
        "bone",
        "marrow",
        "production",
        "disease",
        "need",
        "ceo",
        "research",
        "foundation",
        "therapys",
        "safety",
        "risk",
        "response",
        "toxicity",
        "midstage",
        "trial",
        "disappearance",
        "body",
        "reporting",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}